Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Metadata
Title
Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis
Publication date
01-08-2015
Published in
Calcified Tissue International / Issue 2/2015
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-9993-5

Other articles of this Issue 2/2015

Calcified Tissue International 2/2015 Go to the issue

Original Research

Characterising Bone Material Composition and Structure in the Ovariectomized (OVX) Rat Model of Osteoporosis

Original Research

Involuntary Wheel Running Improves but Does Not Fully Reverse the Deterioration of Bone Structure of Obese Rats Despite Decreasing Adiposity

Editorial

Bisphosphonate Treatment of Children and Adults with Osteogenesis Imperfecta: Unanswered Questions

Original Research

Deletion of Filamin A in Monocytes Protects Cortical and Trabecular Bone from Post-menopausal Changes in Bone Microarchitecture

Original Research

Mechanical Loading Reduces Inflammation-Induced Human Osteocyte-to-Osteoclast Communication

Original Research

Characterisation of Osteoprotegerin Autoantibodies in Coeliac Disease

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits